Life Science companies have an unenviable challenge in today’s climate to bring certified regulated products to market.
The COVID#19 Pandemic highlighted that we need to be able to react quickly to patient’s immediate needs but make sure their safety and quality of the product are not compromised resulting in maximising the clinician and patient experience.
This discussion focuses on positioning Insilco (virtual testing in CAE) as one way to aid shortening project lifecycle and improve patient’s experience.
What is covered?
Who is it for?
If you are in the Life Science industry you shouldn’t miss this opportunity
What’s coming next?
Engineered to Cure